The long-term efficacy of concomitant maze IV surgery in patients with atrial fibrillation

Abstract

BackgroundAtrial fibrillation (AF) is the most common cardiac arrhythmia, and associated with increased risk of morbidity and mortality. AF surgery is widely used for rhythm control of AF, but previous studies have shown varying results. This study sought to investigate the long-term efficacy of concomitant maze IV (CMIV) surgery in an unselected AF population and identify predictors of late AF recurrence.MethodsIn total 144 consecutive patients, who underwent CMIV between January 2006 and December 2010 were enrolled. By data from electronic medical records, registers, and rhythm prints, late AF recurrences and heart rhythm at latest follow-up were retrospectively registered. All patients still alive were invited to an ambulant follow-up to update rhythm status.ResultsDuring a median (IQR) follow-up of 7.39 (2.67) years, 114 (79.2%) patients had recurrence. The cumulative incidence of sinus rhythm (SR) without antiarrhythmic drugs (AADs) was 52.3% after 1 year. Long-term results after 2, 5 and 7 years were 47.9%, 32.6% and 25.1%, respectively. At latest follow-up 34.7% were in SR off AADs. No difference in 10-year event-free survival stratified by recurrence were found (p = 0.678). Contrary, time to death (5.40 vs. 3.43 years, p = 0.004) revealed death as competing risk event. The Fine-Gray model identified preoperative sustained AF (SAF) (SHR 3.54, 95%CI [2.35;5.32], p < 0.001), AF duration (1.08, [1.05;1.11], p < 0.001), and postoperative atrial tachyarrhythmia (ATA) (2.29, [1.21;4.35], p = 0.011) as predictors.ConclusionCMIV in the present cohort provided limited long-term success in obtaining SR. SAF, longer AF duration, and postoperative ATA were associated with late AF recurrence.

Nightly sleep apnea severity in patients with atrial fibrillation: Potential applications of long-term sleep apnea monitoring

“…Atrial fibrillation (AF) is the most common sustained arrhythmia and is associated with significant morbidity, increased risk of stroke, reduced quality of life, and increased mortality [1]. Concomitant risk factors such as hypertension, obesity, metabolic syndrome and ageing lead to structural remodeling processes in the atria which contribute to the progressive nature of AF and the reduced efficacy of standard antiarrhythmic pharmacological and catheter-based rhythm control strategies [2], [3], [4].…”

The gut microbial-derived metabolite trimethylamine N-oxide: A missing link between lifestyle-components and atrial fibrillation?

“…Despite continuous improvement in our knowledge about atrial fibrillation (AF) pathophysiology, pharmacological, ablative and surgical treatments are still suboptimal, so AF remains a challenge of contemporary cardiology [1] , [2] , [3] , [4] . Although there are many well-established predisposing conditions and risk factors for AF, there is still a clear unmet need to expand knowledge of new mechanisms and treatment strategies to reduce morbidity and mortality in AF patients.…”

Genome-wide association studies of atrial fibrillation: Finding meaning in the life of risk loci

“…AF is a progressive arrhythmia with multifactorial etiologies and pathogenesis, and a significant impact on morbidity and mortality [5]. Since rhythm control with catheter ablation or cardiac surgery can be performed in only a limited number of AF patients [6], antiarrhythmic drugs [7] along with anticoagulation for stroke prevention [8] remain the cornerstone of AF management. Several pathological mechanisms, including electrical remodeling, structural remodeling, autonomic imbalance and calcium-handling abnormalities, contribute to the initiation, maintenance and progression of AF (Fig.…”